Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons

Influenza Virus Infection Clinical Trial

— HOSPIGRIP  

Official title:

Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza Seasons. Analysis of Direct Medical Costs

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04008823
• Other study ID #: HOSPIGRIP
• Status: Completed
• Start date: October 5, 2017
• Est. completion date: December 13, 2017

Study information

• Verified date: July 2019
• Source: Asociacion Instituto Biodonostia
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is an epidemiological, retrospective and observational study, by reviewing clinical histories, of children hospitalized for influenza virus infection, their comorbidities and the treatments that have been performed

Description:

A better knowledge in our environment of the characteristics of the Influenza virus infection in the pediatric age, the clinical aspects, risk factors, the evolutionary and prognostic aspects, of morbidity and the direct medical costs, can allow a better management of the disease and a greater awareness of the importance of vaccination against influenza in the healthy child

Recruitment information / eligibility

• Status: Completed
• Enrollment: 907
• Est. completion date: December 13, 2017
• Est. primary completion date: November 2, 2017
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Boys and girls under 15 years of age.

• With a clinical diagnosis of influenza virus infection.

• With infection by influenza virus confirmed microbiologically.

• Hospitalized more than 24 hours

Exclusion Criteria:

• Age equal to or greater than 15 years.

• That the clinical diagnosis is not influenza virus infection.

• Influenza virus not confirmed by microbiological diagnosis.

• Not hospitalized or hospitalized for less than 24 hours.

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Influenza Virus Infection
• Influenza, Human
• Virus Diseases

Intervention

Other:
• Retrospective and observational epidemiological study, by review of clinical histories,
Retrospective and observational epidemiological study, by review of clinical histories,

Locations

Country	Name	City	State
Spain	Iis Biodonostia	San Sebastián	Guipuzcoa

Sponsors (1)

Lead Sponsor	Collaborator
Asociacion Instituto Biodonostia

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To study the rate of hospitalizations for influenza virus infection in children under 15 years of age in third level hospitals in Spain.	Number of hospitalizations in children under 15 years old due to influenza virus infection	2014-2016
Secondary	Hospitalization rate by age groups (0-6 months, 6 months to 24 months, 2 to 6 years, 6 to 10 years and 10 to 15 years of age		2014-2016
Secondary	Demographic characteristics of hospitalizations for influenza in children	Age, sex, weight	2014-2016
Secondary	Complications associated with influenza infection.		2014-2016
Secondary	Related morbidity		2014-2016
Secondary	Estimation of direct costs	Income costs and prescribed medication.; Test costs.; Bed and UCIP costs.; Costs previous visits (to hospitalization) to the emergency room	2014-2016
Secondary	Epidemiological characteristics of hospitalizations for influenza in children	Presence or absence of seasonal influenza vaccination.	2014-2016
Secondary	Clinical characteristics of hospitalizations for influenza in children	Presence / absence in microbiological analysis of influenza virus.; Coinfections.; Presence or absence of complications during hospitalization.; Variables of clinical evolution.; Analytical variables.	2014-2016